These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 21226542)

  • 21. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.
    Sclar DA; Evans MA; Robison LM; Skaer TL
    Clin Drug Investig; 2012 May; 32(5):353-60. PubMed ID: 22480280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
    Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
    Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Augmentation therapy with alpha-1 antitrypsin: 20 year- follow-up of a deficient patient].
    Pujazon MC; Carles P
    Rev Mal Respir; 2008 Nov; 25(9):1136-41. PubMed ID: 19106912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint.
    Miravitlles M; Anzueto A; Barrecheguren M
    Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 38056890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: Updates, challenges and perspectives.
    McNulty MJ; Silberstein DZ; Kuhn BT; Padgett HS; Nandi S; McDonald KA; Cross CE
    Free Radic Biol Med; 2021 Feb; 163():10-30. PubMed ID: 33279618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
    Köhnlein T; Schmidt-Scherzer K; Greulich T; Bals R
    Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of alpha-1 antitrypsin deficiency.
    Ranes J; Stoller JK
    Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.
    Marciniuk DD; Hernandez P; Balter M; Bourbeau J; Chapman KR; Ford GT; Lauzon JL; Maltais F; O'Donnell DE; Goodridge D; Strange C; Cave AJ; Curren K; Muthuri S;
    Can Respir J; 2012; 19(2):109-16. PubMed ID: 22536580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.
    Petrache I; Hajjar J; Campos M
    Biologics; 2009; 3():193-204. PubMed ID: 19707408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous alpha-1 antitrypsin augmentation therapy: systematic review.
    Gøtzsche PC; Johansen HK
    Dan Med Bull; 2010 Sep; 57(9):A4175. PubMed ID: 20816015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Emphysema in a Child With Alpha-1 Antitrypsin Deficiency: Evaluation of 2 Years of Intravenous Augmentation Therapy.
    Esteves Brandão M; Conde B; Seixas S; Clotilde Silva J; Fernandes A
    Arch Bronconeumol (Engl Ed); 2019 Sep; 55(9):502-504. PubMed ID: 30871819
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy for alpha1-antitrypsin deficiency: pharmacology and clinical recommendations.
    Minai OA; Stoller JK
    BioDrugs; 2000 Feb; 13(2):135-47. PubMed ID: 18034520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema.
    Traclet J; Delaval P; Terrioux P; Mornex JF
    Rev Mal Respir; 2015 Apr; 32(4):435-46. PubMed ID: 25908241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation therapy for alpha(1)-antitrypsin deficiency.
    Juvelekian GS; Stoller JK
    Drugs; 2004; 64(16):1743-56. PubMed ID: 15301559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.
    Koepke J; Dresel M; Schmid S; Greulich T; Beutel B; Schmeck B; Vogelmeier CF; Janciauskiene S; Koczulla AR
    PLoS One; 2015; 10(1):e0117497. PubMed ID: 25635861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.